Search by Drug Name or NDC

    NDC 00067-7916-06 Theraflu 650; 20; 10 mg/1; mg/1; mg/1 Details

    Theraflu 650; 20; 10 mg/1; mg/1; mg/1

    Theraflu is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; PHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00067-7916
    Product ID 0067-7916_d8ddbe3f-aaa9-46a9-a96f-11670daec9ac
    Associated GPIs 43994003323050
    GCN Sequence Number 059118
    GCN Sequence Number Description pheniramine/p-eph/acetaminophn PACKET 20-10-650 ORAL
    HIC3 B3O
    HIC3 Description 1ST GEN ANTIHISTAMINE-DECONGESTANT-ANALGESIC COMB
    GCN 24651
    HICL Sequence Number 005286
    HICL Sequence Number Description PHENIRAMINE MALEATE/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Brand
    Proprietary Name Theraflu
    Proprietary Name Suffix Flu and Sore Throat
    Non-Proprietary Name Acetaminophen, Pheniramine Maleate, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 20; 10
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; PHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2022-12-31

    Package

    NDC 00067-7916-06 (00067791606)

    NDC Package Code 0067-7916-06
    Billing NDC 00067791606
    Package 6 PACKET in 1 CARTON (0067-7916-06) / 1 POWDER, FOR SOLUTION in 1 PACKET (0067-7916-01)
    Marketing Start Date 2005-05-13
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 44e1e7b4-d867-4aab-9a51-7a72456eeaa0 Details

    Revised: 8/2020